Clinical Trial Update: Oxaliplatin, Fludarabine, and Cytarabine in Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS) [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating the combination of oxaliplatin, fludarabine, and cytarabine in patients with acute myeloid leukemia or high-risk myelodysp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Fludarabine (Fludarabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Myelodysplastic Syndromes, Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2011-06-30